Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Hologic Inc (HOLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013589
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Hologic Inc, Medical Devices Deals, 2011 to YTD 2017 9
Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Hologic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 11
Asset Transactions 12
KV Pharma Acquires Rights To Makena From Hologic For US$199.5 Million 12
Acquisition 14
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 14
Hologic Inc – Key Competitors 16
Hologic Inc – Key Employees 17
Hologic Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 20
Recent Developments 21
Financial Announcements 21
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 21
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 23
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 25
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 26
Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 28
Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 30
Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 32
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 33
Corporate Communications 35
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 35
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 36
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 37
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 38
Legal and Regulatory 39
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Hologic Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hologic Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Hologic Inc, Medical Devices Deals, 2011 to YTD 2017 9
Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 11
KV Pharma Acquires Rights To Makena From Hologic For US$199.5 Million 12
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 14
Hologic Inc, Key Competitors 16
Hologic Inc, Key Employees 17
Hologic Inc, Other Locations 18
Hologic Inc, Subsidiaries 18
Hologic Inc, Affiliate 20

★海外企業調査レポート[Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • University of Oslo-製薬・医療分野:企業M&A・提携分析
    Summary University of Oslo (UiO), formerly Birkeland Innovation is an educational service provider that offers research and training services. The university offers bachelor degree program, master’s degree program, PhD program; and research-based education. It offers IT services such as username, pa …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • A. Menarini Industrie Farmaceutiche Riunite Srl-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a …
  • American Tower Corporation:企業の戦略・SWOT・財務情報
    American Tower Corporation - Strategy, SWOT and Corporate Finance Report Summary American Tower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Flex Ltd (FLEX):医療機器:M&Aディール及び事業提携情報
    Summary Flex Ltd (Flex) provides design, engineering, manufacturing, and supply chain services to electronics original equipment manufacturers. The company, through its Sketch-to-Scale concept, provides concept design, prototype creation, intellectual property protection, new product introduction, a …
  • Litha Healthcare Group Ltd-医療機器分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Oxford BioMedica Plc (OXB):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform o …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Exact Sciences Corp (EXAS):医療機器:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Canacol Energy Ltd (CNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • QuadraMed Corp-医療機器分野:企業M&A・提携分析
    Summary Quadramed Corporation (Quadramed) is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamlining processes, increase product …
  • RIKEN:製薬・医療:M&Aディール及び事業提携情報
    Summary RIKEN is a research organization that carries out basic and applied science research programs. The organization’s research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, resear …
  • TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Kobe Steel, Ltd.:戦略・SWOT・企業財務分析
    Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Millennium & Copthorne Hotels Plc:戦略・SWOT・企業財務分析
    Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆